What is Neuronetics's total equity?

Neuronetics (STIM) reported total equity of $13.27M in Q1 2026.

How has Neuronetics's total equity changed year-over-year?

Neuronetics's total equity decreased by 62.6% year-over-year, from $35.45M to $13.27M.

What is the long-term trend for Neuronetics's total equity?

Over 5 years (2020 to 2025), Neuronetics's total equity has grown at a -2.6% compound annual growth rate (CAGR), from $25.49M to $22.38M.

What does total equity mean?

Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

Neuronetics STIM Total Equity

Total Equity at other companies

LifeStance Health GroupLFST

$1.48B+1.4%

LBR

LB Pharmaceuticals Inc Common StockLBRX

$378.69M+481%

StereotaxisSTXS

$14.36M+399%

Neuropace, Inc.NPCE

$14.45M-40.4%

Neurocrine BiosciencesNBIX

$3.41B+34.4%

ClearPoint NeuroCLPT

$18.84M-5.7%

Other financials

Income statement

See full

Revenue$34.5M+7.8%

Gross profit$16.2M+2.6%

Operating income-$9.0M+18.3%

Net income-$10.8M+14.9%

EPS (diluted)-$0.16+23.8%

Balance sheet

See full

Cash & equivalents$13.2M-34.7%

Total debt$85.4M+3.5%

Total assets$125.4M-11.7%

Cash flow

See full

Operating cash flow-$9.4M+44.6%

CapEx$197.0K-10.0%

Free cash flow-$9.6M+44.1%

Valuation

See full

Market cap$90.46M-59.6%

Enterprise value$162.64M-44.6%

P/S0.6×-1.4×

Profitability

See full

Gross margin48%-15.6pp

Operating margin-19.4%-6.9pp

Net margin-24.5%-8.7pp

FCF margin-9.4%-4.1pp

Returns & leverage

See full

Return on equity-152.4%-1.4pp

Debt / equity6.4×+4.1×

Current ratio1.7×-0.8×

Where this comes from

Reported directly by Neuronetics in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: Neuronetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neuronetics's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Neuronetics's total equity?: Neuronetics (STIM) reported total equity of $13.27M in Q1 2026.
How has Neuronetics's total equity changed year-over-year?: Neuronetics's total equity decreased by 62.6% year-over-year, from $35.45M to $13.27M.
What is the long-term trend for Neuronetics's total equity?: Over 5 years (2020 to 2025), Neuronetics's total equity has grown at a -2.6% compound annual growth rate (CAGR), from $25.49M to $22.38M.
What does total equity mean?: Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.